EU Commission and Parliament strengthen ties
This article was originally published in Clinica
The European Commission and European Parliament were due to sign a revised Framework Agreement to increase co-operation between the two parties and to strengthen the powers of each individually, as Clinica went to press. Key changes concern establishing a regular political dialogue between the two institutions at the highest possible level and for the Commission to streamline its legislation and work programme timetable so that the process becomes more political. The agreement also provides for more openness on the activities and the composition of such groups, with the aim of enhancing transparency in the EU as a whole. Clinica FILED 1 June 2005 COPYRIGHT T&F Informa UK Ltd 2005
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.